Diamigo i-Phone App The Diamigo app was intended for use as an educational tool in the management of diabetes.
Published January 2, 2013 · Recall initiated: September 21, 2012
Summary
FDA records medical device Class II recall Z-0609-2013, published January 2, 2013 and initiated September 21, 2012. Recalling firm: sanofi-aventis US, Inc.; Status: Terminated; Reported quantity: 1600 downloads (140 US; 1460 Foreign). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Diamigo, a software application, was released through the i-Phone Global Store which inadvertently allowed global access to the application as opposed to the original intended restriction of access to Brazil.
What to do
Voluntary: Firm initiated · Other
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- sanofi-aventis US, Inc.
- Distributor
- Worldwide distribution.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAQualicheck 1+, Aqueous Quality Control, Level 2, S7140, REF 944-042. The solution is used for quality check ofJanuary 2, 2013
- FDAStryker Howmedica Osteonics; Stryker T2 Humerus System Teflon Tube, sterile; REF 1806-0073S The T2 NailingJanuary 2, 2013
- FDAGE Giraffe and Panda T-Piece Resuscitation System labeled ***T-Piece Neonatal Patient Circuit Kit DisposableJanuary 2, 2013
- FDABiosense Webster MobiCath Bi-Directional Guiding Sheath. Small Curve catalog no. D140010, Large Curve catalogJanuary 2, 2013
- FDAEloxatin (OXALIplatin injection) 5 mg/mL Injection, 50 mg, Rx only, Mfd. for: sanofi aventis US LLCJuly 11, 2012
- FDAEloxatin (OXALIplatin injection) 5 mg/mL injection, 100 mg, Rx only, Mfd. for: sanofi aventis US LLCJuly 11, 2012
Questions about this recall
Was Diamigo i-Phone App The Diamigo app was intended for use as an educational tool in the management of diabetes. recalled?
Yes. FDA published recall Z-0609-2013 on January 2, 2013. Reported hazard: Diamigo, a software application, was released through the i-Phone Global Store which inadvertently allowed global access to the application as opposed to the original intended restriction of access to Brazil.
What should I do if I have this product?
Voluntary: Firm initiated · Other